Developing novel miRNA diagnostics to improve human health
What drives us
Explore Hummingbird’s DiagnosticS pipeline for multiple diseases
Broad pipeline of proprietary, miRNA-based diagnostic tests from blood.
PREDICTION OF RESPONSE TO IMMUNOTHERAPY
•Blood-based microRNA panel that predicts immunotherapy response in stage IV NSCLC
•Significant and improved survival prediction (better than PD-L1 staining)
•Significant and immediate value for patients
EARLY DETECTION OF LUNG CANCER
•Blood-based microRNA panel that detects early-stage NSCLC
•Best performance reported from a blood test for early-stage lung cancer
Tackling unmet medical needs
Explore HumminGbird’s Pharma service options
Open to all kinds of partnering and collaboration projects involving small RNAs and Hummingbird’s Next-Gen liquid biopsy technology platform independent of the disease and application.